With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs.

Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves:
•	Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications
•	Site-specific conjugation technology
•	Monoclonal antibodies (mAbs)
•	Highly selective, disease-targeting small molecules

The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.

Biotechnology

Therapeutics

Byondis

Marco Timmers

Ronald Smulders

Norbert Koper

Marieke van Gent

Gerrit Voortman

Aad van de Leur

Wim Dokter

The Leadership Team at Byondis is responsible for steering the strategic direction and overall operations of the company. Comprised of top executives and principal scientists, the team ensures alignment between scientific innovation and business objectives. They drive initiatives to advance the company's precision medicine portfolio, oversee research and development, manage corporate development, and ensure legal and regulatory compliance, all to fulfill the company’s mission of providing novel, effective treatments for cancers and autoimmune diseases.

Leadership Team

Scientific Research and Development

Business Development and Strategic Operations

Leadership Team

About

Team members

Other teams at Byondis

Scientific Research and Development

Business Development and Strategic Operations